Table 2.
Single-Nucleotide Variants With Minor Allele Frequency 0.01 or Higher Meeting Genome-Wide Significance Threshold for Association With Serum Etonogestrel Concentrations Among 880 Contraceptive Implant Users
| rsID | Chr | BP | A1 | A2 | Gene | MAF | β | P |
| rs192047010 | 20 | 50035247 | A | G | NA | 0.011 | 101.87 | 3.27×10−13 |
| rs142433765 | 20 | 49902251 | A | G | NA | 0.011 | 101.39 | 4.11×10−13 |
| rs7549228 | 20 | 49937799 | T | C | RNF114 | 0.012 | 93.55 | 7.41×10−12 |
| rs149649642 | 12 | 126918787 | G | A | LINC02405 | 0.010 | 85.57 | 6.01×10−9 |
| rs372175486 | 6 | 152468357 | G | GT | SYNE1 | 0.011 | 81.78 | 1.08×10−8 |
| rs58877385 | 10 | 80505096 | T | C | TSPAN14 | 0.020 | 65.15 | 1.32×10−8 |
| rs112170255 | 10 | 127597603 | A | G | NA | 0.011 | 79.29 | 1.45×10−8 |
| rs79329941 | 5 | 14089152 | C | T | NA | 0.021 | 56.46 | 1.59×10−8 |
| rs34246968 | 1 | 177960366 | G | C | CRYZL2P-SEC16B | 0.014 | 70.62 | 1.80×10−8 |
| rs145524315 | 4 | 54502499 | CGGTGGTG | C | NA | 0.016 | 66.73 | 1.84×10−8 |
| rs55974552 | 4 | 40335951 | A | G | CHRNA9 | 0.014 | 70.34 | 1.86×10−8 |
| rs137960049 | 3 | 71851406 | T | C | NA | 0.014 | 68.06 | 2.69×10−8 |
| rs564887776 | 6 | 72004251 | G | T | RIMS1 | 0.010 | 81.61 | 2.70×10−8 |
| rs111801179 | 6 | 72011033 | A | C | RIMS1 | 0.010 | 81.61 | 2.70×10−8 |
| rs112741166 | 6 | 72011730 | C | T | RIMS1 | 0.010 | 81.61 | 2.70×10−8 |
| rs61220159 | 14 | 91339460 | T | C | CCDC88C | 0.011 | 71.74 | 4.15×10−8 |
| rs147749042 | 11 | 119244102 | A | C | CBL | 0.013 | 71.71 | 4.30×10−8 |
rsID, reference single nucleotide polymorphism cluster ID; Chr, chromosome; BP, base position; A1, variant (minor) allele; A2, wild-type (major) allele; MAF, minor allele frequency; NA, not applicable.